This is an online event.


Duke-Margolis Events
Duke-Margolis Center for Health Policy

Endpoint Considerations to Facilitate Drug Development for Niemann-Pick Type C (NPC)

In this workshop, participants will discuss clinical endpoints relevant to NPC clinical trials and innovative strategies to support therapeutic development for patients with NPC. January 24, 2022 - 12:00pm - 3:30pm January 25, 2022 - 12:00pm - 3:30pm You may submit comments for this workshop to Docket FDA-2021-N-1297. Docket open until 4/25/22

Registration is closed. This event has already been held.